Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Revenue (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Revenue for 2 consecutive years, with $2.8 million as the latest value for Q2 2025.

  • On a quarterly basis, Revenue changed N/A to $2.8 million in Q2 2025 year-over-year; TTM through Sep 2025 was $2.8 million, a N/A change, with the full-year FY2024 number at $16.1 million, changed N/A from a year prior.
  • Revenue was $2.8 million for Q2 2025 at Pyxis Oncology, down from $16.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $16.1 million in Q1 2024 to a low of $2.8 million in Q2 2025.